New advances in the treatment of hematologic malignancies: focus on topoisomerase I inhibitors. Introduction.
Kantarjian
H
H
M.D. Anderson Cancer Center, Houston, TX 77030, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D059004:Topoisomerase I Inhibitors
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors